Case report
A 74-year-old man was admitted with signs of subileus. His past medical history was unremarkable. He complained about progressive loss of appetite over the previous 3 weeks, accompanied by recurrent vomiting, starting 2 days prior to admission. According to the patient, the most recent bowel movement had occurred 3 days before admission. The physical examination was significant only for mild abdominal pain. A nasogastric tube was inserted, which produced approximately 1.5 l of gastric contents, with no signs of acute bleeding. Results of routine laboratory tests were unremarkable, except for elevated serum creatinine (1.3 mmol/l). Ultrasound examination revealed a large infrarenal aortic aneurysm and grade 1 urinary retention of the left kidney. The aortic aneurysm presented with an eccentric was transferred to a geriatric ward. Unfortunately, the patient died 6 weeks thereafter, due to tumor-related cachexia.
Discussion
Metastases to liver, lungs, bone, and adrenal glands are common events in advanced gastric carcinoma. Occasionally, metastases to other organs, such as the prostate gland [1] , the gluteal muscle [2] , or the cervix [3] are described. To our knowledge, this is the first report of the lymphogenic metastasis of a signet ring cell gastric carcinoma to an aortic aneurysm. The histopathological diagnosis of signet ring cell carcinoma relies on morphological parameters [4] . Signet ring cell histology is found in 3% to 39% of gastric cancer cases and has been reported to be a feature of poor prognosis in advanced gastric cancers [5] ; however, in a recent large series, these findings could not be confirmed [6] . In the patient reported here, infiltration of tumor cells into the aortic wall was noted. The microscopic picture was described by the pathologist as "lymphangiosis carcinomatosa". Histopathological analysis of the surgical specimen did not reveal continuous infiltration from the site of the primary tumor. In addition, neither peritoneal carcinosis nor any other organ involvement could be detected intraoperatively. Thus, in this patient, lymphogenic metastasis seemed to have occurred. A review of the literature revealed several reports of unusual sites of gastric carcinoma metastasis, such as the bulbar conjunctiva [7] , intramuscular metastasis [2] , metastasis to an inguinal hernia [8] , and metastasis to various other sites [9] [10] [11] . In 1967, the simultaneous occurrence of an aortic aneurysm and a gastrointestinal malignancy was first reported in the literature [12] . In the present patient, the aortic aneurysm was resected, because its diameter exceeded the threshold of a 5.5-cm diameter, above which elective surgery is generally recommended [13, 14] . However, had the presence of a gastric carcinoma been known beforehand, careful assessment of the optimal timing for a subsequent surgical intervention would have been performed. Several studies addressing this particular problem have been reported [15] [16] [17] . The overall goal is to prevent tumor cell seeding and contamination of the prosthesis. In most patients, the event with the greater life-threatening potential, i.e., the aneurysm, will be addressed first [15] . In patients with known colorectal cancer and an abdominal aortic aneurysm of 5.5 cm or more, treating the colorectal cancer first may result in life-threatening rupture of the aneurysm. On the other hand, primary treatment of the abdominal aortic aneurysm may significantly delay the treatment of colorectal cancer. According to Baxter et al. [16] , concomitant treatment presents a safe alternative. If anatomically suitable, the abdominal aortic aneurysm may be considered for endovascular repair, followed by a staged colon resection. The presence of an abdominal aortic aneurysm of less than 5.5 cm does not affect colorectal cancer treatment. However, in the present patient, the primary tumor was not yet detected at the time of the initial surgery. Furthermore, the primary tumor might have been unrecognized until further progression. The slightly enlarged lymph nodes detected by the initial MRI scan certainly could have given rise to further diagnostic procedures at that time. However, the observed enlargement was only very moderate and no further signs or symptoms of a malignant disease were present. Thus, no additional diagnostics (such as CT scans with i.v. and oral contrast) were performed. Such scans would most likely have confirmed the diagnosis of concomitant aortic aneurysm and gastric cancer prior to surgery. However, in the present patient, the treatment sequence, i.e., resection of the aneurysm followed by adequate intervention for the gastric cancer, would have been pursued anyway, because the aneurysm was potentially life-threatening.
We have presented a rare case of a gastric malignancy metastasizing into an aortic aneurysm. Clinicians should be aware of this unusual circumstance, because it may have an impact on therapy.
